COVID-19 INFORMATION
IUPHAR’S RESPONSE to COVID-19
IUPHAR is responding to the current crisis by coordinating pharmacological resources worldwide, particularly the responses of the pharmacological community. Although to date most pharmacological studies regarding COVID-19 are limited to adults, we believe that in part it may be relevant for pediatric pharmacologists as well.
Key documents can be found on the following websites:
- Responses of the pharmacological community as well as information about COVID-19 research. This information will be continuously updated:
https://iuphar.org/coronavirus-news
- Pharmacological considerations regarding the COVID-19 Pandemic from the IUPHAR Clinical Division:
- Information about drugs being currently proposed or assessed for treatment:
https://www.guidetopharmacology.org/coronavirus.jsp
- An article on drug testing against SARS-CoV-2 is available in preprint for comments on Authorea "A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development":
Pediatric-pharmacological COVID-19 research
If you are involved in any pediatric-pharmacological COVID-19 research, please let us know at [email protected] . We would be pleased to share the information via our website and our Linked-In channel.
Contact information
ESDPPP VZW p/a University Hospital
Gasthuisberg Herestraat 49
B-3000 Leuven
ESDPPP Mission
The primary aim of the society is to promote research in the field of paediatric pharmacology and to offer a forum for exchange between pharmacologists and clinical physicians about more adequate
drug administration.
Join us on LinkedIn